4//SEC Filing
Donoghoe Nicholas 4
Accession 0001179110-20-002136
CIK 0001551152other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 6:04 PM ET
Size
7.4 KB
Accession
0001179110-20-002136
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
Donoghoe Nicholas
EVP, CHIEF BUS/STRAT OFFICER
Transactions
- Award
Option (right to buy)
2020-02-20+72,013→ 72,013 totalExercise: $93.50From: 2021-02-20Exp: 2030-02-19→ Common Stock (72,013 underlying) - Award
Common Stock, $0.01 par value
2020-02-20+5,316→ 17,504 total
Footnotes (2)
- [F1]Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020.
- [F2]Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 24,005 on February 20, 2021, 24,004 on February 20, 2022, and 24,004 on February 20, 2023.
Documents
Issuer
AbbVie Inc.
CIK 0001551152
Entity typeother
Related Parties
1- filerCIK 0001762951
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 6:04 PM ET
- Size
- 7.4 KB